Adaptimmune Therapeutics plc (ADAP) fell -6.1% or -0.35 to $5.39. It is approximately 327072 shares traded, which is 47.69% compare to the average total volume 685842. The market cap of ADAP is $563.63 million. The year to date change is -2.49%. The 52 week price range is from $3.6 to $14.62. Price of ADAP have changed -5.28% during last week. It have changed 7.09% over last month, -52.72% over last 3 months, -49.38% over last 6 months and -23.57% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ADAP is 5.65. It is 4.82% above current price. The 200-day Moving Averages for ADAP is 10.02. It is 85.90% above current price. The 52-week High is 14.62. It is 171.24% from the current price. The 52-week Low is 3.6. It is -33.21% from current price.
There are some statistics of ADAP. It is has market cap $563.63 million. The share outstanding is 104.57 million. The average volume is 685842. The percent of top 15 Institution holding is 74.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ADAP is -34.29%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ADAP is -28.35%.